SARS-CoV-2 positivity rates associated with circulating 25-hydroxyvitamin D levels
Harvey W Kaufman, Justin K Niles, Martin H Kroll, Caixia Bi, Michael F Holick
PLOS ONE, doi:10.1371/journal.pone.0239252
Until treatment and vaccine for coronavirus disease-2019 (COVID-19) becomes widely available, other methods of reducing infection rates should be explored. This study used a retrospective, observational analysis of deidentified tests performed at a national clinical laboratory to determine if circulating 25-hydroxyvitamin D (25(OH)D) levels are associated with severe acute respiratory disease coronavirus 2 (SARS-CoV-2) positivity rates. Over 190,000 patients from all 50 states with SARS-CoV-2 results performed mid-March through mid-June, 2020 and matching 25(OH)D results from the preceding 12 months were included. Residential zip code data was required to match with US Census data and perform analyses of race/ethnicity proportions and latitude. A total of 191,779 patients were included (median age, 54 years [interquartile range 40.4-64.7]; 68% female. The SARS-CoV-2 positivity rate was 9.3% (95% C.I. 9.2-9.5%) and the mean seasonally adjusted 25(OH)D was 31.7 (SD 11.7). The SARS-CoV-2 positivity rate was higher in the 39,190 patients with "deficient" 25(OH)D values (<20 ng/mL) (12.5%, 95% C.I. 12.2-12.8%) than in the 27,870 patients with "adequate" values (30-34 ng/mL) (8.1%, 95% C.I. 7.8-8.4%) and the 12,321 patients with values �55 ng/mL (5.9%, 95% C.I. 5.5-6.4%). The association between 25 (OH)D levels and SARS-CoV-2 positivity was best fitted by the weighted second-order polynomial regression, which indicated strong correlation in the total population (R 2 = 0.96) and in analyses stratified by all studied demographic factors. The association between lower SARS-CoV-2 positivity rates and higher circulating 25(OH)D levels remained significant in a multivariable logistic model adjusting for all included demographic factors (adjusted odds ratio 0.984 per ng/mL increment, 95% C.I. 0.983-0.986; p<0.001). SARS-CoV-2 positivity is strongly and inversely associated with circulating 25(OH)D levels, a relationship that persists across latitudes, races/ethnicities, both sexes, and age ranges. Our findings provide impetus to explore the role of vitamin D supplementation in reducing the risk for SARS-CoV-2 infection and COVID-19 disease.
Author Contributions Conceptualization: Harvey W. Kaufman, Justin K. Niles, Martin H. Kroll
References
Berry, Hesketh, Power, Hypponen, Vitamin D status has a linear association with seasonal infections and lung function in British adults, The British Journal of Nutrition,
doi:10.1017/S0007114511001991
D'avolio, Avataneo, Manca, 25-Hydroxyvitamin D Concentrations are Lower in Patients with Positive PCR for SARS-CoV-2, Nutrients,
doi:10.3390/nu12051359
Grant, Lahore, Mcdonnell, Evidence that Vitamin D Supplementation Could Reduce Risk of Influenza and COVID-19 Infections and Deaths, Nutrients
Holick, Binkley, Bischoff-Ferrari, Evaluation, Treatment & Prevention of Vitamin D Deficiency: An Endocrine Society Clinical Practice Guideline, J Clin Endocrinol Metab,
doi:10.1210/jc.2011-0385
Ingham, Jones, Camargo, Study, G. Association of vitamin D deficiency with severity of acute respiratory infection: A case-control study in New Zealand children, European Respiratory Journal
Martineau, Jolliffe, Hooper, Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant data, BMJ,
doi:10.1136/bmj.i6583
Rhodes, Dunstan, Laird, COVID-19 mortality increases with northerly latitude after adjustment for age suggesting a link with ultraviolet and vitamin D, BMJ Nutrition, Prevention & Health,
doi:10.1136/bmjnph-2020-000110
Sabetta, Depetrillo, Cipriani, Smardin, Burns et al., Serum 25-hydroxyvitamin d and the incidence of acute viral respiratory tract infections in healthy adults, PLoS One,
doi:10.1371/journal.pone.0011088
Zdrenghea, Makrinioti, Bagacean, Bush, Johnston et al., Vitamin D modulation of innate immune responses to respiratory viral infections, Rev Med Virol,
doi:10.1002/rmv.1909
{ 'indexed': {'date-parts': [[2024, 4, 2]], 'date-time': '2024-04-02T15:10:56Z', 'timestamp': 1712070656293},
'reference-count': 23,
'publisher': 'Public Library of Science (PLoS)',
'issue': '9',
'license': [ { 'start': { 'date-parts': [[2020, 9, 17]],
'date-time': '2020-09-17T00:00:00Z',
'timestamp': 1600300800000},
'content-version': 'vor',
'delay-in-days': 0,
'URL': 'http://creativecommons.org/licenses/by/4.0/'}],
'content-domain': {'domain': ['www.plosone.org'], 'crossmark-restriction': False},
'DOI': '10.1371/journal.pone.0239252',
'type': 'journal-article',
'created': {'date-parts': [[2020, 9, 17]], 'date-time': '2020-09-17T17:48:03Z', 'timestamp': 1600364883000},
'page': 'e0239252',
'update-policy': 'http://dx.doi.org/10.1371/journal.pone.corrections_policy',
'source': 'Crossref',
'is-referenced-by-count': 281,
'title': 'SARS-CoV-2 positivity rates associated with circulating 25-hydroxyvitamin D levels',
'prefix': '10.1371',
'volume': '15',
'author': [ {'given': 'Harvey W.', 'family': 'Kaufman', 'sequence': 'first', 'affiliation': []},
{'given': 'Justin K.', 'family': 'Niles', 'sequence': 'additional', 'affiliation': []},
{'given': 'Martin H.', 'family': 'Kroll', 'sequence': 'additional', 'affiliation': []},
{'given': 'Caixia', 'family': 'Bi', 'sequence': 'additional', 'affiliation': []},
{ 'ORCID': 'http://orcid.org/0000-0001-6023-9062',
'authenticated-orcid': True,
'given': 'Michael F.',
'family': 'Holick',
'sequence': 'additional',
'affiliation': []}],
'member': '340',
'published-online': {'date-parts': [[2020, 9, 17]]},
'reference': [ { 'key': 'pone.0239252.ref001',
'first-page': 'bmjnph-2020',
'article-title': 'COVID-19 mortality increases with northerly latitude after adjustment '
'for age suggesting a link with ultraviolet and vitamin D',
'author': 'J Rhodes',
'year': '2020',
'journal-title': 'BMJ Nutrition, Prevention & Health'},
{ 'key': 'pone.0239252.ref002',
'doi-asserted-by': 'crossref',
'DOI': '10.1136/bmjnph-2020-000096',
'article-title': 'Avoidance of vitamin D deficiency to slow the COVID-19 pandemic',
'volume': '3',
'author': 'M. Kohlmeier',
'year': '2020',
'journal-title': 'BMJ Nutrition, Prevention & Health'},
{ 'key': 'pone.0239252.ref003',
'doi-asserted-by': 'crossref',
'first-page': 'e1909',
'DOI': '10.1002/rmv.1909',
'article-title': 'Vitamin D modulation of innate immune responses to respiratory viral '
'infections',
'volume': '27',
'author': 'MT Zdrenghea',
'year': '2017',
'journal-title': 'Rev Med Virol'},
{ 'issue': '10229',
'key': 'pone.0239252.ref004',
'doi-asserted-by': 'crossref',
'first-page': '1033',
'DOI': '10.1016/S0140-6736(20)30628-0',
'article-title': 'COVID-19: consider cytokine storm syndromes and immunosuppression',
'volume': '395',
'author': 'P Mehta',
'year': '2020',
'journal-title': 'Lancet'},
{ 'issue': '4',
'key': 'pone.0239252.ref005',
'doi-asserted-by': 'crossref',
'first-page': '988',
'DOI': '10.3390/nu12040988',
'article-title': 'Evidence that Vitamin D Supplementation Could Reduce Risk of Influenza '
'and COVID-19 Infections and Deaths',
'volume': '12',
'author': 'WB Grant',
'year': '2020',
'journal-title': 'Nutrients'},
{ 'issue': '5',
'key': 'pone.0239252.ref006',
'first-page': '1359',
'article-title': '25-Hydroxyvitamin D Concentrations are Lower in Patients with Positive '
'PCR for SARS-CoV-2',
'volume': '12',
'author': 'A D’Avolio',
'journal-title': 'Nutrients. 2020'},
{ 'issue': '4',
'key': 'pone.0239252.ref007',
'doi-asserted-by': 'crossref',
'first-page': '561',
'DOI': '10.1016/j.dsx.2020.04.050',
'article-title': 'Vitamin D concentrations and COVID-19 infection in UK Biobank',
'volume': '14',
'author': 'CE Hastie',
'year': '2020',
'journal-title': 'Diabetes Metab Syndr'},
{ 'key': 'pone.0239252.ref008',
'unstructured': 'United States Food and Drug Administration. Quest SARS-CoV-2 rRT-PCR '
'(Quest Diagnostics Infectious Disease, Inc.)–Manufacturer '
'Instructions/Package Insert. https://www.fda.gov/media/136231/download. '
'Accessed August 20, 2020.'},
{ 'key': 'pone.0239252.ref009',
'unstructured': 'United States Food and Drug Administration. cobas SARS-CoV-2 (Roche '
'Molecular Systems, Inc.)–Manufacturer Instructions/Package. '
'https://www.fda.gov/media/136049/download. Accessed August 20, 2020.'},
{ 'key': 'pone.0239252.ref010',
'unstructured': 'United States Food and Drug Administration. Panther Fusion SARS-CoV-2 '
'Assay (Hologic, Inc.)–Manufacturer Instructions/Package. '
'https://www.fda.gov/media/136156/download. Accessed August 20, 2020.'},
{ 'key': 'pone.0239252.ref011',
'unstructured': 'United States Food and Drug Administration. Aptima SARS-CoV-2 '
'assay–Instructions for Use. https://www.fda.gov/media/138096/download. '
'Accessed August 20, 2020.'},
{ 'key': 'pone.0239252.ref012',
'unstructured': 'U.S. Census Bureau; American Community Survey, 2018 American Community '
'Survey 5-Year Estimates, Table B03002; generated by Justin Niles; using '
'data.census.gov; Available from: https://data.census.gov/cedsi/; (1 June '
'2020)'},
{ 'key': 'pone.0239252.ref013',
'article-title': 'Temporal Relationship between Vitamin D Status and Parathyroid Hormone '
'in the United States',
'author': 'MH Kroll',
'year': '2015',
'journal-title': 'PloS ONE'},
{ 'issue': '4',
'key': 'pone.0239252.ref014',
'doi-asserted-by': 'crossref',
'first-page': '239',
'DOI': '10.2174/18715281113129990046',
'article-title': 'The role of vitamin D in prevention and treatment of infection',
'volume': '12',
'author': 'CF Gunville',
'year': '2013',
'journal-title': 'Inflamm Allergy Drug Targets'},
{ 'key': 'pone.0239252.ref015',
'first-page': '439',
'article-title': 'The Whiti Te Ra Study, G. Association of vitamin D deficiency with '
'severity of acute respiratory infection: A case-control study in New '
'Zealand children',
'volume': '44',
'author': 'TR Ingham',
'year': '2014',
'journal-title': 'European Respiratory Journal'},
{ 'key': 'pone.0239252.ref016',
'doi-asserted-by': 'crossref',
'first-page': 'e11088',
'DOI': '10.1371/journal.pone.0011088',
'article-title': 'Serum 25-hydroxyvitamin d and the incidence of acute viral respiratory '
'tract infections in healthy adults',
'volume': '5',
'author': 'JR Sabetta',
'year': '2010',
'journal-title': 'PLoS One'},
{ 'key': 'pone.0239252.ref017',
'doi-asserted-by': 'crossref',
'first-page': 'i6583',
'DOI': '10.1136/bmj.i6583',
'article-title': 'Vitamin D supplementation to prevent acute respiratory tract '
'infections: systematic review and meta‐analysis of individual '
'participant data',
'volume': '356',
'author': 'AR Martineau',
'year': '2017',
'journal-title': 'BMJ'},
{ 'issue': '9',
'key': 'pone.0239252.ref018',
'doi-asserted-by': 'crossref',
'first-page': '1433',
'DOI': '10.1017/S0007114511001991',
'article-title': 'Vitamin D status has a linear association with seasonal infections and '
'lung function in British adults',
'volume': '106',
'author': 'DJ Berry',
'year': '2011',
'journal-title': 'The British Journal of Nutrition'},
{ 'issue': '10',
'key': 'pone.0239252.ref019',
'doi-asserted-by': 'crossref',
'first-page': '993',
'DOI': '10.1111/apt.15752',
'article-title': 'Letter: Covid-19, and vitamin D',
'volume': '51',
'author': 'A Panarese',
'year': '2020',
'journal-title': 'Aliment Pharmacol Ther'},
{ 'issue': '10238',
'key': 'pone.0239252.ref020',
'doi-asserted-by': 'crossref',
'first-page': '1673',
'DOI': '10.1016/S0140-6736(20)31102-8',
'article-title': 'Sharpening the global focus on ethnicity and race in the tie of '
'COVID-19',
'volume': '395',
'author': 'N Bhala',
'year': '2020',
'journal-title': 'Lancet'},
{ 'key': 'pone.0239252.ref021',
'unstructured': 'Centers for Disease Control and Prevention. COVID-19 in Racial and '
'Ethnic Minority Groups. Available from: '
'https://www.cdc.gov/coronavirus/2019-ncov/need-extra-precautions/racial-ethnic-minorities.html#10. '
'Accessed June 4, 2020.'},
{ 'issue': '19',
'key': 'pone.0239252.ref022',
'doi-asserted-by': 'crossref',
'first-page': '1891',
'DOI': '10.1001/jama.2020.6548',
'article-title': 'COVID-19 and African Americans',
'volume': '323',
'author': 'CW Yancy',
'year': '2020',
'journal-title': 'JAMA'},
{ 'issue': '7',
'key': 'pone.0239252.ref023',
'doi-asserted-by': 'crossref',
'first-page': '1911',
'DOI': '10.1210/jc.2011-0385',
'article-title': 'Evaluation, Treatment & Prevention of Vitamin D Deficiency: An '
'Endocrine Society Clinical Practice Guideline',
'volume': '96',
'author': 'MF Holick',
'year': '2011',
'journal-title': 'J Clin Endocrinol Metab'}],
'container-title': 'PLOS ONE',
'original-title': [],
'language': 'en',
'link': [ { 'URL': 'https://dx.plos.org/10.1371/journal.pone.0239252',
'content-type': 'unspecified',
'content-version': 'vor',
'intended-application': 'similarity-checking'}],
'deposited': { 'date-parts': [[2020, 9, 17]],
'date-time': '2020-09-17T17:48:28Z',
'timestamp': 1600364908000},
'score': 1,
'resource': {'primary': {'URL': 'https://dx.plos.org/10.1371/journal.pone.0239252'}},
'subtitle': [],
'editor': [{'given': 'Sakamuri V.', 'family': 'Reddy', 'sequence': 'first', 'affiliation': []}],
'short-title': [],
'issued': {'date-parts': [[2020, 9, 17]]},
'references-count': 23,
'journal-issue': {'issue': '9', 'published-online': {'date-parts': [[2020, 9, 17]]}},
'URL': 'http://dx.doi.org/10.1371/journal.pone.0239252',
'relation': {},
'ISSN': ['1932-6203'],
'subject': ['Multidisciplinary'],
'container-title-short': 'PLoS ONE',
'published': {'date-parts': [[2020, 9, 17]]}}